News

Citizens JMP Downgrades Blueprint Medicines (BPMC) to Market Perform
Citizens JMP analyst Reni Benjamin downgraded Blueprint Medicines Corporation (NASDAQ:BPMC) to Market Perform from Outperform ...
Chemistry World1d
Sanofi to buy Blueprint Medicines for over $9 billion
As part of a strategy to strengthen its immunology segment through acquisitions, Sanofi has agreed to buy US-based Blueprint ...
Kalkine Media1d
Nasdaq Today Blueprint Medicines Reclassified Kalkine
The stock, trading under the ticker (NASDAQ:BPMC), is a part of both the Nasdaq Biotechnology Index and the Nasdaq Today.
Why Blueprint Medicines Corporation (BPMC) Skyrocketed On Monday
We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where ...
These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, GM, Blueprint Medicines, BioNTech, DraftKings, and More
Wall Street stocks closed higher Monday as the U.S. and China accused one another of violating a 90-day trade truce they had ...
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in ...
Sanofi finds M&A fix for its multiple itches
The French drugmaker will pay up to $9.5 bln for Blueprint Medicines, whose key product fights skin rashes. It eases CEO Paul ...